On ECHEMI
Home > Drugs > Cerebral hemorrhage
Cerebral hemorrhage
Cerebral hemorrhage, also known as cerebral hemorrhage, has various causes, most of which are caused by rupture of blood vessels due to hypertension and arteriosclerosis, so some people also call it hypertensive cerebral hemorrhage. According to whether it is caused by traumatic factors, it can be divided into traumatic intraventricular hemorrhage and spontaneous intraventricular hemorrhage. The close relationship between cerebral hemorrhage and hypertension is that about 1/3 of patients with hypertension have a chance of cerebral hemorrhage, and about 95% of patients with cerebral hemorrhage have hypertension. Cerebral hemorrhage is a common acute cerebrovascular disease in middle-aged and elderly people, with a high mortality rate and disability rate. It is the clinical type with the highest mortality rate among cerebrovascular diseases in my country. Cerebral hemorrhage accounts for 40% to 50% of all cerebrovascular diseases. 80% of cerebral hemorrhage occurs in the cerebral hemispheres, and 20% occurs in the lobes, brainstem, cerebellum and ventricles.
Related Drugs
Cinnarizine Tablets
Indication: It is used to treat cerebral thrombosis, cerebral embolism, cerebral arteriosclerosis, cerebral hemorrhage recovery period, subarachnoid hemorrhage recovery period, sequelae of brain trauma, inner ear vertigo, coronary artery sclerosis and diseases caused by poor peripheral circulation. In recent years, relevant literature reports show that this product can be used for allergic skin diseases such as chronic urticaria and senile skin itching.
Manufacturer:

Hebei Changshan Biochemical Pharmaceutical Co., Ltd.

Cinnarizine Tablets
Indication: It is used to treat cerebral thrombosis, cerebral embolism, cerebral arteriosclerosis, cerebral hemorrhage recovery period, subarachnoid hemorrhage recovery period, sequelae of brain trauma, inner ear vertigo, coronary artery sclerosis and diseases caused by poor peripheral circulation. In recent years, relevant literature reports show that this product can be used for allergic skin diseases such as chronic urticaria and senile skin itching.
Manufacturer:

Hebei Hengli Group Pharmaceutical Co., Ltd.

Adenosine triphosphate disodium injection
Indication: Coenzyme drugs. Used as an adjuvant treatment for progressive muscular atrophy, sequelae of cerebral hemorrhage, heart failure, myocardial disease and hepatitis, etc.
Manufacturer:

Guangzhou Baiyunshan Mingxing Pharmaceutical Co., Ltd.

Adenosine triphosphate disodium injection
Indication: Coenzyme drugs. Used as an adjuvant treatment for progressive muscular atrophy, sequelae of cerebral hemorrhage, heart failure, myocardial disease and hepatitis, etc.
Manufacturer:

Gansu Lanyao Pharmaceutical Co., Ltd.

Adenosine triphosphate disodium injection
Indication: Coenzyme drugs. Used as an adjuvant treatment for progressive muscular atrophy, sequelae of cerebral hemorrhage, heart failure, myocardial disease and hepatitis, etc.
Manufacturer:

Topfond Pharmaceutical Co., Ltd.

Adenosine triphosphate disodium injection
Indication: Coenzyme drugs. Used as an adjuvant treatment for progressive muscular atrophy, sequelae of cerebral hemorrhage, heart failure, myocardial disease and hepatitis, etc.
Manufacturer:

Duoduo Pharmaceutical Co., Ltd.

Adenosine triphosphate disodium injection
Indication: Coenzyme drugs. Used as an adjuvant treatment for progressive muscular atrophy, sequelae of cerebral hemorrhage, heart failure, myocardial disease and hepatitis, etc.
Manufacturer:

Hubei Tiansheng Pharmaceutical Co., Ltd.

Adenosine triphosphate disodium injection
Indication: Coenzyme drugs. Used as an adjuvant treatment for progressive muscular atrophy, sequelae of cerebral hemorrhage, heart failure, myocardial disease and hepatitis, etc.
Manufacturer:

Hubei Zhongjia Pharmaceutical Co., Ltd.

Adenosine triphosphate disodium injection
Indication: Coenzyme drugs. Used as an adjuvant treatment for progressive muscular atrophy, sequelae of cerebral hemorrhage, heart failure, myocardial disease and hepatitis, etc.
Manufacturer:

Wuhan Changlian Laifu Pharmaceutical Co., Ltd.

Adenosine triphosphate disodium injection
Indication: Coenzyme drugs. Used as an adjuvant treatment for progressive muscular atrophy, sequelae of cerebral hemorrhage, heart failure, myocardial disease and hepatitis, etc.
Manufacturer:

Changzhou Lanling Pharmaceutical Co., Ltd.

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.